Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

ALLOALLO
Showing 8 of 25 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in ALLOGENE THERAPEUTICS INC

TWO SIGMA INVESTMENTS, LP holds 7.8M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $16.2M as of 2026-Q2. The position was increased (+44.8% shares). ALLO represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$16.2M

Current Shares

7.8M

Total Value Change

+$8.4M

Total Shares Change

+5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.8M
+44.8%
$16.2M0.0%$2.08
38
2026-Q1
Increased
5.4M
+57.0%
$13.1M0.0%$2.53
40
2025-Q4
Increased
3.4M
+1.2%
$4.7M0.0%$1.31
27
2025-Q3
Increased
3.4M
+109.7%
$4.2M0.0%$1.27
43
2025-Q2
Decreased
1.6M
-22.3%
$1.8M0.0%$1.18
0
2025-Q1
Decreased
2.1M
-23.5%
$3M0.0%$1.55
0
2024-Q4
Decreased
2.7M
-3.1%
$5.8M0.0%$2.10
0
2024-Q3
Decreased
2.8M
-5.5%
$7.8M0.0%$2.91
0

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used